Piqray OverviewAlpelisib, sold under the brand name Piqray (as Pivikto in emerging markets), is a medication sold by Novartis and used to treat certain types of breast cancer. It is used together with fulvestrant. It is taken by mouth.it is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced ...
Read more Piqray Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alpelisib
Recent Piqray Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 150mg, 200mg, 50mg
NDC Database Records for Piqray: (3 results)Sorted by National Drug Code
- 0078-0701 Piqray 200 mg Oral Tablet by Novartis Pharmaceuticals Corporation
- 0078-0708 Piqray 150 mg Oral Tablet by Novartis Pharmaceuticals Corporation
- 0078-0715 PiqrayPiqray Kit by Novartis Pharmaceuticals Corporation